| Mark E Senior, DO | |
|
525 E Market St, Akron, OH 44304-1619 | |
| (330) 375-3786 | |
| Not Available |
| Full Name | Mark E Senior |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 525 E Market St, Akron, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639130719 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 34-004860 (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mark E Senior, DO 2600 Sixth St Sw, Suite 1, Canton, OH 44710-1702 Ph: (800) 288-8325 | Mark E Senior, DO 525 E Market St, Akron, OH 44304-1619 Ph: (330) 375-3786 |
News Archive
Linguistic Systems, Inc. (LSI), a leading provider of language translation services, is proud to announce the success of the LSI Foundation's Pro Bono Program, providing translation and interpreting services to those organizations serving the community, and specifically enabling LSI employees to give back to their community. The LSI staff has seen the difference the program has made for local organizations and has decided to increase their contributions through the fall.
Senesco Technologies, Inc. announced today that Catherine Taylor, one of the Company's funded researchers, will be presenting pre-clinical stability and biological activity data on SNS-01, Senesco's multiple myeloma drug candidate, at the 2009 American Association for Cancer Research (AACR)-National Cancer Institute (NCI)-European Organization for Research and Treatment of Cancer (EORTC) Molecular Targets and Cancer Therapeutics Conference.
The breakthrough, published in the journal Nature Materials, could offer an easier way of detecting pathogenic bacteria outside of a clinical setting and could be particularly important for the developing world, where access to more sophisticated laboratory techniques is often limited.
Scientists have identified some of the first genetic triggers for cancer as mutations in specific oncogenes or tumor suppressor genes. Full-blown tumors and metastatic cancers, however, often exhibit many genetic mutations, sometimes dozens in a given tumor. An important scientific question, and one with significant clinical implications, has been what happens after the initial mutation that leads to dangerous later-stage cancers with multiple damaged genes.
A single antibody could be the key to treating multiple myeloma, or cancer of the blood, currently without cure or long-term treatment.
› Verified 7 days ago
Dr. Thomas Hlivko, Pathology Medicare: Accepting Medicare Assignments Practice Location: 2215 E Waterloo Rd, Ste 313, Akron, OH 44312 Phone: 330-208-2720 Fax: 330-208-2721 | |
Dr. William Arthur Henthorne, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3786 Fax: 330-375-4874 | |
Eric Douglas Speakman, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 400 Wabash Ave, Akron, OH 44307 Phone: 330-344-2025 Fax: 330-344-6418 | |
Dr. Steven Michael Thompson, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-9678 | |
Dr. Caroline Mitchell Abramovich, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3786 Fax: 330-375-4874 | |
Silvia Deperalta, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 525 E Market St, Akron, OH 44304 Phone: 330-375-3786 Fax: 330-375-4874 | |
Dimitris P Agamanolis, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8572 Fax: 330-543-3226 |